17 August
Ian Bremmer, a political scientist and author, shared an article on the doubts cast on Russia’s new Covid-19 vaccine.
Go deeper with GlobalData
Developed by the Gamaleya institute in Moscow, the vaccine has been approved by Russian health authorities without undergoing phase III clinical trials required to prove the efficacy and safety of the vaccine.
Although Russia has announced mass vaccination to begin in October, the effectiveness of the vaccine is yet to be known.
If the vaccine in fact proves effective, it could provide several advantages to Russia.
Firstly, the vaccine could enable Russia’s economy to recover faster than the other countries.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe demand for vaccine will also increase boosting the country’s global image, while generating huge revenues.
However, if the vaccine proves ineffective Russia’s image could be badly damaged.
In other news, Prof. Steve Hanke, an economist at Johns Hopkins, shared an article on how Sweden adopted a laissez-faire approach to the pandemic and experience fewer deaths per capita and half the GDP decline of 8.6%.
The article noted that using a slightly variant approach adopted by Sweden instead of a complete lockdown could have helped with UK’s economic recovery.
Hanke noted that the UK National Health Service is the most overrated health system in the world.
